000 01372 a2200373 4500
005 20250517132616.0
264 0 _c20170905
008 201709s 0 0 eng d
022 _a1875-5992
024 7 _a10.2174/1871520617666170103095527
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuan, Haixing
245 0 0 _aDevelopment of Selective Cyclin-Dependent Kinase 4 Inhibitors for Antineoplastic Therapies.
_h[electronic resource]
260 _bAnti-cancer agents in medicinal chemistry
_c2017
300 _a646-657 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCyclin-Dependent Kinase 4
_xantagonists & inhibitors
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Screening Assays, Antitumor
650 0 4 _aHumans
650 0 4 _aModels, Molecular
650 0 4 _aMolecular Structure
650 0 4 _aProtein Kinase Inhibitors
_xchemistry
650 0 4 _aStructure-Activity Relationship
700 1 _aDu, Yongli
700 1 _aHan, Weiwei
700 1 _aShen, Jingkang
700 1 _aLi, Qunyi
773 0 _tAnti-cancer agents in medicinal chemistry
_gvol. 17
_gno. 5
_gp. 646-657
856 4 0 _uhttps://doi.org/10.2174/1871520617666170103095527
_zAvailable from publisher's website
999 _c26748241
_d26748241